Suppr超能文献

多学科心力衰竭门诊对指南指导药物治疗及临床结局的影响

Impact of Multidisciplinary Heart Failure Clinic on Guideline-Directed Medical Therapy and Clinical Outcomes.

作者信息

Tan Sie Sie, Hisham Shairyzah Ahmad, Bin Abdul Malek Abdul Muizz, Lik Chua Ping, Lau Glendon Seng Kiong, Bin Abdul Ghapar Abdul Kahar

机构信息

, BScPhm, RPh, MClinPharm, is a clinical pharmacist with Sultan Idris Shah Serdang Hospital, Selangor, Malaysia.

, PhD, MedSc, is with the Faculty of Pharmacy, University of Cyberjaya, Selangor, Malaysia.

出版信息

Can J Hosp Pharm. 2024 Jan 10;77(1):e3364. doi: 10.4212/cjhp.3364. eCollection 2024.

Abstract

BACKGROUND

Heart failure (HF) is associated with recurrent hospital admissions and high mortality. Guideline-directed medical therapy has been shown to improve prognosis for patients who have HF with reduced ejection fraction (HFrEF). Despite the proven benefits of guideline-directed medical therapy, its utilization is less than optimal among patients with HF in Malaysia.

OBJECTIVE

To determine the impact of a multidisciplinary team HF (MDT-HF) clinic on the use of guideline-directed medical therapy and patients' clinical outcomes at 1 year.

METHODS

This retrospective study was conducted in a single cardiac centre in Malaysia. Patients with HFrEF who were enrolled in the MDT-HF clinic between November 2017 and June 2020 were compared with a matched control group who received the standard of care. Data were retrieved from the hospital electronic system and were analyzed using statistical software.

RESULTS

A total of 54 patients were included in each group. Patients enrolled in the MDT-HF clinic had higher usage of renin-angiotensin system blockers (54 [100%] vs 47 [87%], p < 0.001) and higher attainment of the target dose for these agents (35 [65%] vs 5 [9%], p < 0.001). At 1 year, the mean left ventricular ejection fraction (LVEF) was significantly greater in the MDT-HF group (35.7% [standard deviation 12.3%] vs 26.2% [standard deviation 8.7%], p < 0.001), and care in the MDT-HF clinic was significantly associated with better functional class, with a lower proportion of patients categorized as having New York Heart Association class III HF at 1 year (1 [2%] vs 14 [26%], p = 0.001). Patients in the MDT-HF group also had a significantly lower rate of readmission for HF (4 [7%] vs 32 [59%], p < 0.001).

CONCLUSIONS

Patients who received care in the MDT-HF clinic had better use of guideline-directed medical therapy, greater improvement in LVEF, and a lower rate of readmission for HF at 1 year relative to patients who received the standard of care.

摘要

背景

心力衰竭(HF)与反复住院和高死亡率相关。对于射血分数降低的心力衰竭(HFrEF)患者,指南指导的药物治疗已被证明可改善其预后。尽管指南指导的药物治疗已证实具有益处,但在马来西亚的HF患者中,其使用率仍未达到最佳水平。

目的

确定多学科团队心力衰竭(MDT-HF)门诊对指南指导的药物治疗的使用情况以及患者1年临床结局的影响。

方法

本回顾性研究在马来西亚的一个心脏中心进行。将2017年11月至2020年6月期间纳入MDT-HF门诊的HFrEF患者与接受标准治疗的匹配对照组进行比较。数据从医院电子系统中获取,并使用统计软件进行分析。

结果

每组共纳入54例患者。纳入MDT-HF门诊的患者肾素-血管紧张素系统阻滞剂的使用率更高(54例[100%]对47例[87%],p<0.001),且这些药物达到目标剂量的比例更高(35例[65%]对5例[9%],p<0.001)。1年时,MDT-HF组的平均左心室射血分数(LVEF)显著更高(35.7%[标准差12.3%]对26.2%[标准差8.7%],p<0.001),并且MDT-HF门诊的治疗与更好的功能分级显著相关,1年时被归类为纽约心脏协会III级HF的患者比例更低(1例[2%]对14例[26%],p = 0.001)。MDT-HF组患者因HF再次入院的发生率也显著更低(4例[7%]对32例[59%],p<0.001)。

结论

与接受标准治疗的患者相比,在MDT-HF门诊接受治疗的患者对指南指导的药物治疗的使用情况更好,LVEF改善更大,且1年时因HF再次入院的发生率更低。

相似文献

本文引用的文献

5
Trends in 30- and 90-Day Readmission Rates for Heart Failure.心力衰竭 30 天和 90 天再入院率的趋势。
Circ Heart Fail. 2021 Apr;14(4):e008335. doi: 10.1161/CIRCHEARTFAILURE.121.008335. Epub 2021 Apr 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验